Yannick Brüggemann

10PUBLICATIONS
34CO-AUTHORS
Major global burdens of diseaseEpidemiological modellingMedical molecular engineering of nucleic acids and proteinsMolecular targetsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 08, 2026
Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection.

Julian J Ring, Sarah Schlienkamp, Maria L Goussain Darido

|Nov 15, 2024
Modeling extrahepatic hepatitis E virus infection in induced human primary neurons.

Michelle Jagst, André Gömer, Sanja Augustyniak

|Jul 22, 2024
Hepatitis E virus: from innate sensing to adaptive immune responses.

Yannick Brüggemann, Mara Klöhn, Heiner Wedemeyer

|May 10, 2024
Targeting cellular cathepsins inhibits hepatitis E virus entry.

Mara Klöhn, Thomas Burkard, Juliana Janzen

|Feb 06, 2023
EGF receptor modulates HEV entry in human hepatocytes.

Jil A Schrader, Thomas L Burkard, Yannick Brüggemann

|Aug 15, 2022
A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.

Toni Luise Meister, Yannick Brüggemann, Maximilian K Nocke

Pageof 2

Frequent Collaborators

5 joint publications

Daniel Todt

3 joint publications

Eike Steinmann

3 joint publications

Mara Klöhn

3 joint publications

Viet Loan Dao Thi